Host: Jonathan Barratt, PhD <br>


  
    <p>A new class of drugs are looking at the ability to reduce proteinuria and protect the loss of kidney function. So what do clinicians need to know about the treatment landscape for IgA nephropathy? Tune in with Dr. Jonathan Barratt, The Mayer Professor of Renal Medicine at the University of Leicester in the United Kingdom.</p>

Host: Jonathan Barratt, PhD A new class of drugs are looking at the ability to reduce proteinuria and protect the loss of kidney function. So what do clinicians need to know about the treatment landscape for IgA nephropathy? Tune in with Dr. Jonathan Barratt, The Mayer Professor of Renal Medicine at the University of Leicester in the United Kingdom.

Taking a Deep Dive into the Pathophysiology of IgA Nephropathy

Tune in to interviews with the top thought leaders in medicine exploring the clinical and professional issues that are foremost in the minds of the medical community. Join us at the Clinician's Roundtable for discussions on a vast range of topics that every medical professional should know about.

Share Taking a Deep Dive into the Pathophysiology of IgA Nephropathy

Sign up to save your podcasts

Taking a Deep Dive into the Pathophysiology of IgA Nephropathy

Taking a Deep Dive into the Pathophysiology of IgA Nephropathy

More shows like Clinician's Roundtable

The Peter Attia Drive

Huberman Lab